Related Experiment Video
Updated: Nov 6, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital
Bharat Kumar1, Madhukar Mittal1, Maya Gopalakrishnan1
1All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Insights
Admission plasma glucose levels in hospitalized COVID-19 patients are a strong predictor of mortality. Higher glucose levels correlate with increased risk, especially in patients with diabetes mellitus.
Area of Science:
- Infectious Diseases
- Endocrinology
- Critical Care Medicine
Background:
- Plasma glucose levels are linked to mortality in various diseases, including infections.
- Understanding glucose's role in COVID-19 is crucial for patient management.
Purpose of the Study:
- To investigate the association between plasma glucose at admission and mortality in hospitalized COVID-19 patients in Jodhpur, India.
- To explore the relationship between glucose levels, disease severity, and patient outcomes.
Main Methods:
- A hospital-based clinical study involving 386 COVID-19 patients from May 15 to June 30, 2020.
- Collected random blood samples for plasma glucose, interleukin-6 (IL6), and high-sensitivity C-reactive protein (hsCRP) assays.
- Analyzed data to correlate glucose levels with mortality, disease severity, and inflammatory markers.
Main Results:
- A total of 386 patients were studied; 4.1% expired. Patients with known diabetes mellitus had three times higher mortality.
- Higher plasma glucose levels were observed in patients with moderate to severe COVID-19 and in non-survivors.
- Plasma glucose strongly correlated with inflammatory markers (IL6 and hsCRP) and increased mortality risk with rising glucose levels.
Conclusions:
- Plasma glucose at admission is a significant predictor of mortality in hospitalized COVID-19 patients.
- Elevated glucose levels indicate a poorer prognosis and are associated with increased inflammation.
Objective:
Plasma glucose has been correlated with in-hospital mortality among many diseases including infections. We aimed to study the plasma glucose at the admission of hospitalized patients with COVID-19 at a tertiary care referral hospital at Jodhpur, India and its relation with mortality.
Design:
A hospital-based clinical study of plasma glucose of COVID-19 patients conducted from May 15 to June 30, 2020 after ethical approval.
Measurements:
Random blood samples at admission were collected for plasma glucose, interleukin-6 (IL6) and high sensitivity C-reactive protein (hsCRP) after written informed consent was obtained. Plasma glucose was analyzed by the automated analyzer, IL6 by chemiluminescent immunoassay and hsCRP by immune-turbidimetric assay.
Results:
A total of 386 patients were studied (female 39.6%); 11.1% had severe disease and 4.1% expired. There were 67 (17.4%) patients with known diabetes mellitus (DM). Patients with a history of DM had three times higher mortality (6/67, 9%) than those without DM (10/309, 3.1%). Patients with moderate and severe disease according to ICMR and WHO grading had higher plasma glucose than those with asymptomatic or mild disease (P < 0.0001). Plasma glucose levels at admission were significantly higher in non-survivors when compared to those who survived (297 ± 117 vs 131 ± 73; P < 0.0001). COVID-19 patients showed increased mortality with incremental plasma glucose levels. The hazard ratio for mortality was 1.128 (95% CI 0.86-14.860), 1.883 (95% CI 0.209-16.970), and 4.005 (95% CI 0.503-32.677) in random plasma glucose group of >100-200, >200-300 and >300 mg/dL, respectively, compared to those with random plasma glucose of <100 mg/dL at admission. Plasma glucose was strongly correlated with hsCRP (P < 0.001) and IL6 (P < 0.0001).
Conclusions:
Plasma glucose at admission in hospitalized COVID-19 patients is a strong predictor of mortality.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes: Symptoms, Diagnosis, and Complications

